225 related articles for article (PubMed ID: 9647594)
1. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.
Younossi ZM; Gramlich T; Liu YC; Matteoni C; Petrelli M; Goldblum J; Rybicki L; McCullough AJ
Mod Pathol; 1998 Jun; 11(6):560-5. PubMed ID: 9647594
[TBL] [Abstract][Full Text] [Related]
2. Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology.
Gawrieh S; Knoedler DM; Saeian K; Wallace JR; Komorowski RA
Ann Diagn Pathol; 2011 Feb; 15(1):19-24. PubMed ID: 21106424
[TBL] [Abstract][Full Text] [Related]
3. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease.
Merriman RB; Ferrell LD; Patti MG; Weston SR; Pabst MS; Aouizerat BE; Bass NM
Hepatology; 2006 Oct; 44(4):874-80. PubMed ID: 17006934
[TBL] [Abstract][Full Text] [Related]
4. Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease.
Mendler MH; Kanel G; Govindarajan S
Liver Int; 2005 Apr; 25(2):294-304. PubMed ID: 15780053
[TBL] [Abstract][Full Text] [Related]
5. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.
Mofrad P; Contos MJ; Haque M; Sargeant C; Fisher RA; Luketic VA; Sterling RK; Shiffman ML; Stravitz RT; Sanyal AJ
Hepatology; 2003 Jun; 37(6):1286-92. PubMed ID: 12774006
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.
Larson SP; Bowers SP; Palekar NA; Ward JA; Pulcini JP; Harrison SA
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1329-32. PubMed ID: 17702661
[TBL] [Abstract][Full Text] [Related]
7. The histologic spectrum of nonalcoholic fatty liver disease.
Contos MJ; Choudhury J; Mills AS; Sanyal AJ
Clin Liver Dis; 2004 Aug; 8(3):481-500, vii. PubMed ID: 15331059
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of histological features in non-alcoholic fatty liver disease.
Vasdev N; Kakati AG; Saigal S; Nayak NC
Natl Med J India; 2007; 20(6):282-7. PubMed ID: 18335793
[TBL] [Abstract][Full Text] [Related]
9. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
Sanyal AJ; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Stravitz RT; Mills AS
Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
[TBL] [Abstract][Full Text] [Related]
11. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease. Correlation with histology and viral hepatitis.
Akyol G; Erdem O; Yilmaz G
Saudi Med J; 2005 Dec; 26(12):1904-10. PubMed ID: 16380770
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].
Kim KO; Park SH; Park CH; Han TH; Yoo KS; Kim JH; Lee MS; Kim DJ; Park CK; Cho HD
Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885
[TBL] [Abstract][Full Text] [Related]
14. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
[TBL] [Abstract][Full Text] [Related]
15. The comparison of scoring scales for liver biopsy assessment in morbidly obese patients undergoing bariatric surgery.
Ziolkowski A; Wylezol M; Kukla M; Zwirska-Korczala K; Berdowska A; Pardela M; Gabriel A
Obes Surg; 2005 Oct; 15(9):1309-14. PubMed ID: 16259893
[TBL] [Abstract][Full Text] [Related]
16. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
17. High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease.
Forlano R; Mullish BH; Giannakeas N; Maurice JB; Angkathunyakul N; Lloyd J; Tzallas AT; Tsipouras M; Yee M; Thursz MR; Goldin RD; Manousou P
Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2081-2090.e9. PubMed ID: 31887451
[TBL] [Abstract][Full Text] [Related]
18. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ
J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042
[TBL] [Abstract][Full Text] [Related]
19. Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease.
Bedossa P;
Hepatology; 2014 Aug; 60(2):565-75. PubMed ID: 24753132
[TBL] [Abstract][Full Text] [Related]
20. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.
Adams LA; Sanderson S; Lindor KD; Angulo P
J Hepatol; 2005 Jan; 42(1):132-8. PubMed ID: 15629518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
